相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents
So Takata et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
Re-activation of pulmonary tuberculosis during anti-programmed death-1 (PD-1) treatment
C. -C Tsai et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2019)
Tuberculosis following PD-1 blockade for cancer immunotherapy
Daniel L. Barber et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Development of pulmonary tuberculosis following treatment with anti-PD-1 for non-small cell lung cancer
Kristian Hastoft Jensen et al.
ACTA ONCOLOGICA (2018)
Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment
H. Picchi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research
Naomi F. Walker et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report
Wan He et al.
ONCOTARGETS AND THERAPY (2018)
Pericardial Tamponade Caused by a Hypersensitivity Response to Tuberculosis Reactivation after Anti–PD-1 Treatment in a Patient with Advanced Pulmonary Adenocarcinoma
Yi-Chun Chu et al.
Journal of Thoracic Oncology (2017)
Supportive care for patients undergoing immunotherapy
Bernardo Leon Rapoport et al.
SUPPORTIVE CARE IN CANCER (2017)
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
Liting Guo et al.
JOURNAL OF CANCER (2017)
Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma
Joycelyn J. X. Lee et al.
ACTA ONCOLOGICA (2016)
MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage
N. T. T. Thuong et al.
GENES AND IMMUNITY (2016)
Prevention and Treatment of Cancer-Related Infections, Version 2.2016
Lindsey Robert Baden et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Anti-PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
Thanyanan Reungwetwattana et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
Kohei Fujita et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
Shunsuke Sakai et al.
PLOS PATHOGENS (2016)
A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitorsaEuro
T. W. Chen et al.
ANNALS OF ONCOLOGY (2015)
Smoking and Mortality - Beyond Established Causes
Brian D. Carter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Interferon-gamma Inhibits Nonopsonized Phagocytosis of Macrophages via an mTORC1-c/EBP beta Pathway
Zengfu Wang et al.
JOURNAL OF INNATE IMMUNITY (2015)
Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities
Jeryl Villadolid et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2015)
Opportunistic infections in patients treated with immunotherapy for cancer
Chrisann Kyi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study
S-C Kuo et al.
BRITISH JOURNAL OF CANCER (2013)
CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition
Daniel L. Barber et al.
JOURNAL OF IMMUNOLOGY (2011)
T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection
Sultan Tousif et al.
PLOS ONE (2011)
Tuberculosis and malignancy
M. E. Falagas et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
MARCO, TLR2, and CD14 Are Required for Macrophage Cytokine Responses to Mycobacterial Trehalose Dimycolate and Mycobacterium tuberculosis
Dawn M. E. Bowdish et al.
PLOS PATHOGENS (2009)
Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection
Keer Sun et al.
NATURE MEDICINE (2008)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
